In the News

1910 News Items found
An MSK researcher reviews images on a screen
MSK Research Highlights, September 14, 2026
New MSK research shows how a metabolite boosts immune cells against cancer; adds to the understanding of how colorectal cancer spreads; reveals tumor CD19 levels may predict the success of CAR T cell therapy; and finds a new targeted drug combination shows promise in early trial for small cell lung cancer.
MSK patient Joanne Ferrari-Mautino seen outdoors with her son and boyfriend.
Learn how MSK is helping people with lung cancer driven by ROS1 fusions, thanks to continual improvements in specific targeted therapies.
Caleb Lareau
Using AI To Design Better Cancer Therapies
How MSK researchers are using artificial intelligence (AI) to design better "binders" for CAR T cell therapies.
Doctors Nancy Lee, Alan Ho, and Richard Wong are seen discussing a medical image.
Learn how MSK's world-class Head and Neck cancer specialists help people facing throat cancer, using the latest therapies and innovations.
Dr. Geoffrey Ku
For patients who are newly diagnosed with gastroesophageal adenocarcinoma, the most common type of stomach and esophageal cancer, the FDA has approved zanidatamab as an additional medication for those who are getting chemotherapy.
MSK radiation oncologist Nancy Lee
In the Clinic
Learn how HPV-related head and neck cancer can be treated with a sharply reduced radiation dose to prevent side effects, sometimes without surgery.
Thoracic medical oncologist Dr. Mark Awad
Ask the Expert
Learn about the latest advances in lung cancer treatment at MSK.
MSK's Mark Awad, MD, PhD, is seen smiling.
Learn about the questions to ask a lung cancer doctor after being diagnosed, from an MSK specialist who has successfully treated many people for lung cancer.
A person's hand holds a syringe, with its needle inserted into a vial of clear liquid
Peptides have become popular with many health and fitness influencers, but experts from MSK say they have concerns about cancer patients using these products because they have not been tested in clinical trials.
MSK thoracic oncologist Kathryn Arbour, MD, seen smiling.
A heralded drug that experts hope will open a new era in treating pancreatic cancer is also showing early but strong signs it could be effective agains...